These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 9214282)
1. [Enhancement of treatment efficacy in experimental plague by the sequential administration of antibiotics]. Makarovskaia LN; Tinker LA; Markovskaia EI; Zurabian VA; Ryzhkova VV Antibiot Khimioter; 1996; 41(11):25-7. PubMed ID: 9214282 [TBL] [Abstract][Full Text] [Related]
2. [A method of sequential administration of antibiotics in preventive treatment of experimental plague in albino mice]. Makarovskaia LN; Tinker LA; Markovskaia EI; Zurabian VA Antibiot Khimioter; 1994 May; 39(5):41-4. PubMed ID: 7857160 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effect of azlocillin and its combinations with other antibiotics in experimental plague infection]. Markovskaia EI; Makarovskaia LN; Ryzhkova VV; Zurabian VA Antibiot Khimioter; 1993 Jul; 38(7):37-9. PubMed ID: 8161276 [TBL] [Abstract][Full Text] [Related]
4. [Detoxifying effect of antibiotics and their effectiveness in experimental plague at the stage of explicit intoxication]. Makarovskaia LN; Glian'ko EV; Tinker LA; Kasatkin IuA; Ryzhkova VV; Bozhko NV; Kozyreva LA Antibiot Khimioter; 1992 Nov; 37(11):30-2. PubMed ID: 1300933 [TBL] [Abstract][Full Text] [Related]
5. [Combined use of quinolones with other antibiotics in treatment of experimental plague infection]. Shcherbaniuk AI; Kasatkina IV; Ryzhko IV Antibiot Khimioter; 1994 May; 39(5):38-40. PubMed ID: 7857159 [TBL] [Abstract][Full Text] [Related]
6. [Synergistic action of some antibacterial agents in studies on albino mice with experimental plague caused by Fr- phenotype strain of the plague microbe]. Shcherbaniuk AI; Liukshina EIu; Ryzhko IV; Smorodinova IuV Antibiot Khimioter; 2006; 51(1):7-10. PubMed ID: 16734358 [TBL] [Abstract][Full Text] [Related]
7. [Increased effectiveness of etiotropic therapy of experimental plague in albino mice at the stage of generalized infection]. Ryzhkova VV; Pavlovich NV; Makarovskaia LN; Zurabian VA; Bespalova IA; Goncharov EK; Bugaeva OK; Malsova NN Antibiot Khimioter; 1996 Feb; 41(2):35-9. PubMed ID: 8929117 [TBL] [Abstract][Full Text] [Related]
8. [Comparative effectiveness of rifampicin for parenteral administration and internal dose in the treatment of experimental plague in albino mice]. Makarovskaia LN; Ryzhkova VV; Zurabian VA; Bugaeva OK; Pasiukov VV; Fomina IP; Navashin SM Antibiot Khimioter; 1995 Jun; 40(6):37-9. PubMed ID: 8593093 [TBL] [Abstract][Full Text] [Related]
9. [Prophylactic and therapeutic action of ceftazidime in comparison to that of cefotaxime and combined use of cefotaxime with other antibiotics in experimental plague of albino mice]. Zurabian VA; Markovskaia EI; Ryzhkova VV; Makarovskaia LN Antibiot Khimioter; 1994; 39(9-10):40-4. PubMed ID: 7695449 [TBL] [Abstract][Full Text] [Related]
10. [Characteristics of etiotropic therapy of plaque infection induced by atypical strains of F1- phenotype plaque microbe]. Ryzhko IV; Samokhodkina ED; Tsuraeva RI; Shcherbaniuk AI; Tsetskhladze NS Antibiot Khimioter; 1998; 43(9):24-8. PubMed ID: 9791683 [TBL] [Abstract][Full Text] [Related]
11. [Methods for rapid evaluation of the effectiveness of drugs showing promise for urgent prevention and treatment of plague]. Romanov VE; Vasil'ev NT; Shabalin BA; Kozhemiako AV; Zhivov IV Antibiot Khimioter; 1995 Jun; 40(6):31-6. PubMed ID: 8593092 [TBL] [Abstract][Full Text] [Related]
12. Comparison between the combination of azlocillin-gentamicin and ampicillin-gentamicin in the treatment of a nursery population. Fogel D; Farfel L; Miskin A; Mogilner BM Isr J Med Sci; 1983 Nov; 19(11):1009-15. PubMed ID: 6662683 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic treatment of experimental pneumonic plague in mice. Byrne WR; Welkos SL; Pitt ML; Davis KJ; Brueckner RP; Ezzell JW; Nelson GO; Vaccaro JR; Battersby LC; Friedlander AM Antimicrob Agents Chemother; 1998 Mar; 42(3):675-81. PubMed ID: 9517950 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy of rifampicin in experimental plague infection]. Makarovskaia LN; Shcherbaniuk AI; Bugaeva OK Antibiot Khimioter; 1993 Jul; 38(7):34-6. PubMed ID: 8161275 [TBL] [Abstract][Full Text] [Related]
15. Relationship between the chemotherapeutic effectiveness of ciclacillin and ampicillin and the time of their administration in experimental infections. Arend P; Sous H; Poszich G; Mŭckter H Arzneimittelforschung; 1975 Sep; 25(9):1382-5. PubMed ID: 1103895 [TBL] [Abstract][Full Text] [Related]
16. Adjunctive treatment with low-dose polymyxin B improves operant response rates and latency in infant rats with Haemophilus influenzae type b meningitis. Walterspiel JN; Vitulli WF Pediatr Res; 1989 Nov; 26(5):496-9. PubMed ID: 2554243 [TBL] [Abstract][Full Text] [Related]
17. [Multifactorial study of the combined effect of rifampicin and microbial peptidoglycan in experimental plague infection]. Nikitin AV; Makarovskaia LN; Fomina IP; Ivanitskaia LP; Popova GO; Vinidchenko NN; Korganov IaN; Bodunkova LE Antibiot Khimioter; 1991 May; 36(5):23-5. PubMed ID: 1953166 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of subinhibitory polymyxin B alone and in combination with ampicillin for overwhelming Haemophilus influenzae type B infection in the infant rat: evidence for in vivo and in vitro release of free endotoxin after ampicillin treatment. Walterspiel JN; Kaplan SL; Mason EO Pediatr Res; 1986 Mar; 20(3):237-41. PubMed ID: 3010223 [TBL] [Abstract][Full Text] [Related]
19. [Ofloxacin efficacy in the prophylaxis and treatment of experimental plague due to antigen complete and defective strains of the pathogen]. Samokhodkina ED; Shcherbaniuk AI; Ryzhko IV; Tsuraeva RI; Skalyga EIu Antibiot Khimioter; 2002; 47(3):26-9. PubMed ID: 16127904 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin. Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]